---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-032612"
form_type: "8-K"
ticker: "MNPR"
cik: "0001645469"
company_name: "Monopar Therapeutics"
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:19:09.581730+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Monopar Therapeutics prices $19.2M public stock offering at $16.25 per share

## Summary
- Gross proceeds ~$19.2M from offering of up to 1,181,540 shares at $16.25/share.
- Participating investors include Janus Henderson, RA Capital Management, L.P.
- Net proceeds to be used for R&D, clinical trials, manufacture, and working capital.
- Offering closed October 30, 2024; Rodman & Renshaw acted as placement agent.
- Placement agent fee is 7.0% of gross proceeds plus expense reimbursement.

## SEC filing metadata
- accession: 0001437749-24-032612
- form_type: 8-K
- ticker: MNPR
- cik: 0001645469
- company_name: Monopar Therapeutics
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645469/000143774924032612/0001437749-24-032612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645469/000143774924032612/mnpr20241029_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-032612
- JSON: https://secwatch.observer/filing/0001437749-24-032612.json
- Plain text: https://secwatch.observer/filing/0001437749-24-032612.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.